Securities code: Star Lake Bioscience Co.Inc.Zhaoqing Guangdong(600866) securities abbreviation: Star Lake Bioscience Co.Inc.Zhaoqing Guangdong(600866) Announcement No.: pro 2022018 Star Lake Bioscience Co.Inc.Zhaoqing Guangdong(600866)
Announcement on the forecast of daily connected transactions in 2022
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Important content tips: ● whether it needs to be submitted to the general meeting of shareholders for deliberation: no ● impact of daily connected transactions on Listed Companies: This connected transaction is a daily connected transaction of Guangdong Zhaoqing Xinghu Biotechnology Co., Ltd. (hereinafter referred to as “the company”), with fair and reasonable pricing, following the principles of equality, voluntariness and good faith, and there is no damage to the interests of the company and shareholders, The company will not rely on related parties due to daily related party transactions.
1、 Basic information of daily connected transactions
(I) review procedures for the performance of daily connected transactions
Upon prior review and approval by the independent directors and the audit committee of the board of directors of the company, it is agreed to submit the expected matters of daily connected transactions in 2022 to the board of directors of the company for deliberation. On March 25, 2022, the board of directors of the company held the 15th meeting of the 10th board of directors, deliberated and adopted the proposal on the prediction of daily connected transactions in 2022. Related directors Wang Li and Pang Bixia avoided voting, six non related Directors voted unanimously, and independent directors expressed their consent.
The total amount of connected transactions in the proposal does not reach more than 5% of the absolute value of the company’s latest audited net assets, so it is not necessary to submit it to the general meeting of shareholders for deliberation.
(II) forecast and implementation of related party transactions in 2021
Reasons for the difference between the estimated amount in 2021 and the actual amount of related party transactions in 2021 (RMB 10000) and the actual amount of related party’s accrual (RMB 10000)
To the related person Guangdong Zhujiang bridge biotechnology shares 193.99
Sales of goods Guangdong Guangfen Co., Ltd. and its related parties
New holding set
Not applicable to affiliated corporations
The purchase commodity department and its customs have invested 10.44% in Yangcheng health, Guangdong Province
/Accept Lecong branch of labor union Co., Ltd
Affairs
Total / 500204.43 n / A
(III) estimated amount and category of daily connected transactions in 2022
Estimated amount of inter gold incurred by related parties of actual connected transactions in 2022 and 2021 (10000 yuan)
There are 193.99 sales of commodity Holding Group Co., Ltd. and its related parties to Guangdong Guangxin Guangdong Zhujiang bridge Biotechnology Co., Ltd
Limited company and other related parties
Other related parties 10.44
Total / 500204.43
2、 Introduction and relationship of related parties
(I) introduction to related parties
1. Guangdong Guangxin Holding Group Co., Ltd
Legal representative: Bai Tao;
Registered capital: 300 million yuan;
Registered address: room 1601, East Tower, poly World Trade Center, No. 1000, Xingang East Road, Haizhu District, Guangzhou, Guangdong Province;
Date of establishment: September 6, 2000;
Business scope: equity management; Equity investment; Research, development, production and sales: new materials (alloy materials and profiles, functional films and composites, electronic substrate sectors, power battery materials), biomedicine (chemical and biological drugs), food (condiments and additives); Digital creativity and integrated services; High end equipment manufacturing; Information technology services; E-commerce operation; Development, investment and management of modern agriculture; International Trade and Chinese trade; International Economic and technical cooperation; Property leasing and management. (for projects subject to approval according to law, business activities can be carried out only after approval by relevant departments)
The audited main financial indicators of Guangdong Guangxin Holding Group Co., Ltd. in 2020 are: total assets of 66.744 billion yuan, net assets of 26.134 billion yuan, main business income of 71.137 billion yuan and net profit of 2.692 billion yuan.
2. Guangdong Zhujiang bridge Biotechnology Co., Ltd
Legal representative: Wei Gaoping;
Registered capital: 167852000 yuan;
Registered address: Shakou Industrial Development Zone, Xiaolan Town, Zhongshan City, Guangdong Province;
Date of establishment: February 25, 1991;
Business scope: research and development of food production technology; Food production and food business (including online sales); Sales and online sales: daily necessities, arts and crafts (except ivory and its products), by-products (except live poultry, fresh meat, vegetables and aquatic products); Import and export of goods or technologies (excluding those prohibited by the state or involving administrative examination and approval)
Main unaudited financial indicators of Guangdong Zhujiang bridge Biotechnology Co., Ltd. in 2021: total assets of 690 million yuan, net assets of 607 million yuan, main business income of 396 million yuan and net profit of 256962 million yuan.
(II) relationship between related parties and the company
Guangdong Guangxin Holding Group Co., Ltd. is the controlling shareholder of the company. Through its wholly-owned subsidiary, Guangdong food import and Export Group Co., Ltd., it holds 31.64% equity of Guangdong Zhujiang bridge Biotechnology Co., Ltd. and is its actual controller.
(III) analysis on the performance capacity of related parties.
The above-mentioned related parties exist and operate in accordance with the law, have good credit status and financial status, and have strong ability to perform and pay. The company and related parties strictly follow the agreement. The performance of both parties has legal guarantee and will not cause bad debt losses to the company.
3、 Pricing policy and basis
The transactions between the company and the above related parties are carried out in accordance with the principles of openness, fairness and impartiality and in combination with the market price. The prices of related party transactions refer to the external prices of similar services of the company and the market transaction prices.
4、 Purpose of related party transactions and its impact on Listed Companies
The above connected transactions are normal business transactions within the daily business scope of the company and will not affect the normal production, operation and financial status of the company; The relevant price is determined at the fair price of the market, which does not damage the interests of non related shareholders, will not have an adverse impact on the company’s future financial status and operating results, will not rely on related parties, and will not affect the independence of the listed company. It is hereby announced.
Board of directors
March 29, 2022
